price apr usd
stronger growth outlook fx
hold rate reect skeptic compani
abl attain sale growth margin target result
report sales/ep beat miss meaning margin support
thing like
organ sale growth beat estim consensu
out-performance da segment oset
under-perform diagnost segment rais fy
sale outlook bil reect stronger organ growth
base busi euroimmun well better fx environ
compani also rais adjust ep guidanc
biopharma aca/gov growth drove out-performance da organ
sale growth discoveri analyt servic da segment
outpac forecast consensu high-
singl digit sale growth pharma/biotech end market contribut
out-performance specic manag call robust
growth informat onesourc servic oer aca/gov
sale growth anoth bright spot quarter acceler mid-
singl digit growth pace low-singl digit declin prior quarter
broad-bas geograph strength china growth continu robust
pace report solid growth across geograph region
china grew mid-teen rate quarter equat
fourth consecut quarter double-digit growth sale america
acceler mid-singl digit pace low-singl digit prior
quarter sale growth europ deceler low-teen still came
healthi mid-singl digit pace
thing cautiou
call meaning expans remaind year adjust
ebit margin declin bp y/i came well
forecast manag attribut lion share impact
fx bp compar restat ebit margin
also note season weaker protabl euroimmun
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
also contribut bp arm expect bp
adjust oper margin expans fy euroimmun
contribut margin expans acceler year ultim
exit bp contribut adjust ebit margin
diagnost core growth miss forecast diagnost busi
post organ growth came consensus-
like forecast manag attribut deceler
prior quarter tough prior year compar inde appli
genom sale declin y/i due tough comp microuid sale
addit infecti diseas test sale grew solid mid-teen
pace reproduct health grew mid-singl digit china newborn
screen partial oset dicult comparison
continu soft industri end market report
soft industri end market second consecut quarter
inde relat compani appli end market slight
declin industri weigh mid-singl digit growth food
environment end market specic manag call
weak chemic sector time instrument order
geograph industri sale growth oset
weak europ asia plu side note solid order
growth quarter
forecast ratio
period end expens expens incom incom continu ep dilut con share share sale ex amort acquir cash flowoper cash cash revenu ep incl
period end asset equival st receiv current discontinu current equip secur asset asset asset discontinu liabil short-term liabil discontinu op current debt less current long-term liabil stockhold april
